Wang, S.; Qi, G.; Zhang, Z.; Yin, Q.; Li, N.; Li, Z.; Shi, G.; Hu, H.; Hao, L.
cRGD-Conjugated GdIO Nanoclusters for the Theranostics of Pancreatic Cancer through the Combination of T1–T2 Dual-Modal MRI and DTX Delivery. Molecules 2023, 28, 6134.
https://doi.org/10.3390/molecules28166134
AMA Style
Wang S, Qi G, Zhang Z, Yin Q, Li N, Li Z, Shi G, Hu H, Hao L.
cRGD-Conjugated GdIO Nanoclusters for the Theranostics of Pancreatic Cancer through the Combination of T1–T2 Dual-Modal MRI and DTX Delivery. Molecules. 2023; 28(16):6134.
https://doi.org/10.3390/molecules28166134
Chicago/Turabian Style
Wang, Shengchao, Guiqiang Qi, Zhichen Zhang, Qiangqiang Yin, Na Li, Zhongtao Li, Guangyue Shi, Haifeng Hu, and Liguo Hao.
2023. "cRGD-Conjugated GdIO Nanoclusters for the Theranostics of Pancreatic Cancer through the Combination of T1–T2 Dual-Modal MRI and DTX Delivery" Molecules 28, no. 16: 6134.
https://doi.org/10.3390/molecules28166134
APA Style
Wang, S., Qi, G., Zhang, Z., Yin, Q., Li, N., Li, Z., Shi, G., Hu, H., & Hao, L.
(2023). cRGD-Conjugated GdIO Nanoclusters for the Theranostics of Pancreatic Cancer through the Combination of T1–T2 Dual-Modal MRI and DTX Delivery. Molecules, 28(16), 6134.
https://doi.org/10.3390/molecules28166134